Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
The company sells anti-ageing products for hair, skin and body.
Patients access the treatment through their doctor under the TGA’s Special Access Scheme.
The patent was granted by the State Intellectual Property Office of China.
The Australian regenerative medicine company is developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence-driven strategy.
The company’s HeraBEAT device is a smartphone-based home fetal heart rate monitoring solution.
Both Ms Zhang and Dr Wu bring commercial and scientific experience and networks in China.
PromarkerD is the world's first commercial test for predicting the onset of diabetic kidney disease.
Uniquely designed patient study which allows the comparison of multiple drugs on the same patient at the same time.